TOLL-LIKE RECEPTORS IN ISCHEMIA-REPERFUSION INJURY

被引:308
作者
Arumugam, Thiruma V. [1 ]
Okun, Eitan [2 ]
Tang, Sung-Chun [3 ]
Thundyil, John [1 ]
Taylor, Stephen M. [4 ]
Woodruff, Trent M. [4 ]
机构
[1] Texas Tech Univ, Hlth Sci Ctr, Dept Pharmaceut Sci, Sch Pharm, Amarillo, TX 79106 USA
[2] NIA, Neurosci Lab, Intramural Res Program, Baltimore, MD 21224 USA
[3] Natl Taiwan Univ Hosp, Dept Neurol, Yunlin, Taiwan
[4] Univ Queensland, Sch Biomed Sci, Brisbane, Qld, Australia
来源
SHOCK | 2009年 / 32卷 / 01期
关键词
Toll-like receptors; ischemia-reperfusion injury; myocardial infarction; neuron; stroke; apoptosis; NF-KAPPA-B; MEDIATES ISCHEMIA/REPERFUSION INJURY; NECROSIS-FACTOR-ALPHA; IN-VIVO EXPRESSION; OXIDATIVE STRESS; INFLAMMATORY RESPONSE; DENDRITIC CELLS; INNATE IMMUNITY; UP-REGULATION; LUNG INJURY;
D O I
10.1097/SHK.0b013e318193e333
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Ischemia-reperfusion (I/R) injuries are implicated in a large array of pathological conditions such as myocardial infarction, cerebral stroke, and hepatic, renal, and intestinal ischemia, as well as following cardiovascular and transplant surgeries. The hallmark of these pathologies is excessive inflammation. Toll-like receptors (TLRs) are recognized as one of the main contributors to pathogen-induced inflammation and, more recently, injury-induced inflammation. Endogenous ligands such as low-molecular hyaluronic acid, fibronectin, heat shock protein 70, and heparin sulfate were all found to be cleaved in the inflamed tissue and to activate TLR2 and TLR4, initiating an inflammatory response even in the absence of pathogens and infiltrating immune cells. In this review, we discuss the contribution of TLR activation in hepatic, renal, cerebral, intestinal, and myocardial I/R injuries. A greater understanding of the role of TLRs in I/R injuries may aid in the development of specific TLR-targeted therapeutics to treat these conditions.
引用
收藏
页码:4 / 16
页数:13
相关论文
共 158 条
  • [1] Signaling danger:: Toll-like receptors and their potential roles in kidney disease
    Anders, HJ
    Banas, B
    Schlöndorff, D
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2004, 15 (04): : 854 - 867
  • [2] Toll-like receptor 2 is protective of ischemia-reperfusion-mediated small-bowel injury in a murine model
    Aprahamian, Charles J.
    Lorenz, Robin G.
    Harmon, Carroll M.
    Dimmit, Reed A.
    [J]. PEDIATRIC CRITICAL CARE MEDICINE, 2008, 9 (01) : 105 - 109
  • [3] Targeting ischemic brain injury with intravenous immunoglobulin
    Arumugam, Thiruma V.
    Selvaraj, Pradeep K.
    Woodruff, Trent M.
    Mattson, Mark P.
    [J]. EXPERT OPINION ON THERAPEUTIC TARGETS, 2008, 12 (01) : 19 - 29
  • [4] Intravenous immunoglobulin (IVIG) protects the brain against experimental stroke by preventing complement-mediated neuronal cell death
    Arumugam, Thiruma V.
    Tang, Sung-Chun
    Lathia, Justin D.
    Cheng, Aiwu
    Mughal, Mohamed R.
    Chigurupati, Srinivasulu
    Magnus, Tim
    Chan, Sic L.
    Jo, Dong-Gyu
    Ouyang, Xin
    Fairlie, David P.
    Granger, Daniel N.
    Vortmeyer, Alexander
    Basta, Milan
    Mattson, Mark P.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (35) : 14104 - 14109
  • [5] Complement mediators in ischemia-reperfusion injury
    Arumugam, Thiruma V.
    Magnus, Tim
    Woodruff, Trent M.
    Proctor, Lavinia M.
    Shiels, Ian A.
    Taylor, Stephen M.
    [J]. CLINICA CHIMICA ACTA, 2006, 374 (1-2) : 33 - 45
  • [6] Gamma secretase-mediated notch signaling worsens brain damage and functional outcome in ischemic stroke
    Arumugam, TV
    Chan, SL
    Jo, DG
    Yilmaz, G
    Tang, SC
    Cheng, AW
    Gleichmann, M
    Okun, E
    Dixit, VD
    Chigurupati, S
    Mughal, MR
    Ouyang, X
    Miele, L
    Magnus, T
    Poosala, S
    Granger, DN
    Mattson, MP
    [J]. NATURE MEDICINE, 2006, 12 (06) : 621 - 623
  • [7] Stroke and T-cells
    Arumugam, TV
    Granger, DN
    Mattson, MP
    [J]. NEUROMOLECULAR MEDICINE, 2005, 7 (03) : 229 - 242
  • [8] Protective effect of a human C5a receptor antagonist against hepatic ischaemia-reperfusion injury in rats
    Arumugam, TV
    Woodruff, TM
    Stocks, SZ
    Proctor, LM
    Pollitt, S
    Shiels, IA
    Reid, RC
    Fairlie, DP
    Taylor, SM
    [J]. JOURNAL OF HEPATOLOGY, 2004, 40 (06) : 934 - 941
  • [9] The role of the complement system in ischemia-reperfusion injury
    Arumugam, TV
    Shiels, IA
    Woodruff, TM
    Granger, DN
    Taylor, SM
    [J]. SHOCK, 2004, 21 (05): : 401 - 409
  • [10] A small molecule C5a receptor antagonist protects kidneys from ischemia/reperfusion injury in rats
    Arumugam, TV
    Shiels, IA
    Strachan, AJ
    Abbenante, G
    Fairlie, DP
    Taylor, SM
    [J]. KIDNEY INTERNATIONAL, 2003, 63 (01) : 134 - 142